Amikacin Sulfate



Indications and Reactions:

Role Indications Reactions
Primary
Pneumonia 11.3%
Sepsis 10.4%
Tuberculosis 9.4%
Antibiotic Therapy 7.5%
Acute Lymphocytic Leukaemia 6.6%
Cystic Fibrosis 5.7%
Mycobacterium Abscessus Infection 4.7%
Pulmonary Tuberculosis 4.7%
Antiretroviral Therapy 3.8%
Bartholinitis 3.8%
Lung Infection 3.8%
Mycobacterial Infection 3.8%
Staphylococcal Infection 3.8%
Urinary Tract Infection 3.8%
Acute Myeloid Leukaemia 2.8%
Blood Culture Positive 2.8%
Bronchopneumonia 2.8%
Febrile Neutropenia 2.8%
Infection 2.8%
Meningitis Bacterial 2.8%
Candida Sepsis 11.6%
Acute Generalised Exanthematous Pustulosis 7.0%
Death 7.0%
Drug Ineffective 7.0%
Neutropenic Colitis 7.0%
Thrombocytopenia 7.0%
Dyspnoea 4.7%
Enterocolitis 4.7%
Mycobacterial Infection 4.7%
Mycobacterium Abscessus Infection 4.7%
Neutropenia 4.7%
Renal Failure Acute 4.7%
Renal Impairment 4.7%
Restlessness 4.7%
Tubulointerstitial Nephritis 4.7%
Back Pain 2.3%
Deafness 2.3%
Depression 2.3%
Drug Rash With Eosinophilia And Systemic Symptoms 2.3%
Grand Mal Convulsion 2.3%
Secondary
Pneumonia 16.7%
Drug Use For Unknown Indication 13.4%
Pyrexia 12.7%
Sepsis 9.3%
Product Used For Unknown Indication 7.2%
Bacteraemia 4.5%
Acute Myeloid Leukaemia 4.0%
Febrile Neutropenia 3.6%
Infection Prophylaxis 3.4%
Hypertension 2.7%
Mediastinal Abscess 2.7%
Retroperitoneal Abscess 2.7%
B-cell Lymphoma 2.2%
Lung Disorder 2.2%
Septic Shock 2.2%
Abscess 2.1%
Antifungal Prophylaxis 2.1%
Bronchopulmonary Aspergillosis 2.1%
Hiv Infection 2.1%
Lung Abscess 2.1%
White Blood Cell Disorder 10.7%
Renal Impairment 9.3%
Vomiting 8.0%
Wheezing 8.0%
Pyrexia 6.7%
Toxic Epidermal Necrolysis 6.7%
Deafness 5.3%
Thrombocytopenia 5.3%
Liver Disorder 4.0%
Neutropenia 4.0%
Rash 4.0%
Septic Shock 4.0%
Transaminases Increased 4.0%
White Blood Cell Count Decreased 4.0%
Cerebellar Syndrome 2.7%
Depression 2.7%
Dermatitis Exfoliative 2.7%
Hepatic Failure 2.7%
Hepatotoxicity 2.7%
Jaundice 2.7%
Concomitant
Drug Use For Unknown Indication 19.6%
Prophylaxis 14.8%
Hiv Infection 12.5%
Product Used For Unknown Indication 10.6%
Infection Prophylaxis 7.5%
Mycobacterium Avium Complex Infection 4.4%
Aplastic Anaemia 3.9%
Acute Myeloid Leukaemia 3.4%
Pneumonia 2.8%
Bone Marrow Conditioning Regimen 2.6%
Prophylaxis Against Graft Versus Host Disease 2.4%
Antifungal Prophylaxis 2.3%
Cytomegalovirus Infection 2.2%
Hypertension 1.9%
Stem Cell Transplant 1.7%
Pyrexia 1.6%
Infection 1.5%
Premedication 1.5%
Allogenic Bone Marrow Transplantation Therapy 1.5%
Febrile Neutropenia 1.5%
Vomiting 15.1%
White Blood Cell Count Decreased 14.3%
Pyrexia 7.8%
Sepsis 7.3%
Septic Shock 6.5%
Liver Disorder 4.5%
Stomatitis 4.5%
Pneumonia 4.1%
Weight Increased 4.1%
Venoocclusive Liver Disease 3.7%
Respiratory Failure 3.3%
Retinal Haemorrhage 3.3%
Shock 3.3%
Staphylococcal Infection 3.3%
Pseudomembranous Colitis 2.9%
Infection 2.4%
Platelet Count Decreased 2.4%
Renal Impairment 2.4%
Small Intestinal Perforation 2.4%
Syncope 2.4%
Interacting
General Anaesthesia 100.0%
Potentiating Drug Interaction 100.0%